Depressed scars are characterized by localized loss or depression of soft tissue below the surrounding skin surface. For appropriate indications, an injectable HA filler can be used to provide volume within the treatment area and reduce the visible depth of the depression.
Unlike surface skincare products, an injectable scar filler requires controlled gel properties, sterile manufacture, consistent filling volume, and predictable injection behavior.
For procurement teams, these factors are directly relevant to product quality, clinical handling, regulatory submission, and batch-to-batch consistency. The manufacturing infrastructure encompasses controlled formulation facilities, automated sterile filling systems, and dedicated analytical laboratories to support scalable commercial supply.
Key Product Specifications
|
Parameter |
Specification |
|
Product Name |
Hyaluronic Acid Depressed Scar Filler |
|
Material |
Hyaluronic Acid (HA) |
|
Gel Type |
Cross-linked / non-cross-linked HA according to product model |
|
HA Concentration |
Available according to product specification |
|
Syringe Volume |
Available according to product model |
|
Injection Needle Configuration |
Available according to product specification |
|
Appearance |
Sterile, homogeneous injectable gel |
|
Packaging |
Prefilled syringe with sterile primary packaging |
|
Sterilization Method |
According to validated manufacturing process |
|
Shelf Life |
According to product registration and stability data |
|
Storage Conditions |
According to product labeling |
|
Supply Model |
OEM / Private Label / Bulk Distributor |
|
Regulatory Documentation |
Available for applicable target markets |
Product Advantages
Precision Rheological Control: Offers customized elastic modulus and viscosity designs tailored to the tissue firmness and structural support requirements of various depressed scars, ensuring seamless integration with surrounding subcutaneous tissue post-injection.
High-Purity Raw Material Extraction: Utilizes medical-grade, high-purity sodium hyaluronate raw materials with endotoxin and protein residue levels controlled to strict international standards, minimizing the risk of postoperative inflammatory reactions.
Superior Biocompatibility: Advanced homogenization and cross-linking technologies yield fine, uniform gel particles that provide smooth and stable extrusion resistance, optimizing clinical handling and reducing localized irregularities or nodule formation.
Long-Lasting Support and Stability: Optimized cross-linking structures effectively slow down enzymatic degradation in vivo, maintaining prolonged smoothness and structural support in targeted scar areas.
Full-Chain Sterile Smart Manufacturing: Backed by class-10,000 cleanrooms and automated sterile filling systems, ensuring zero-defect microbiological control for every prefilled syringe.
Typical Application
The product is intended for use in aesthetic medical procedures involving selected depressed or atrophic scar areas where an injectable HA filler is clinically appropriate.
Depressed Acne Scars
Localized depressed scars associated with previous acne lesions may require assessment of scar morphology, depth, tissue quality, and surrounding skin before selecting an injectable filler.
Atrophic Scars
HA-based soft-tissue fillers may be considered for selected atrophic scar presentations where additional volume beneath the depression is clinically appropriate.
Localized Soft-Tissue Depressions
The product may be considered for localized contour irregularities within the approved indication of the specific product model.
Manufacturing and Quality Considerations
For injectable medical devices, manufacturing control extends beyond the initial raw material. Important production controls include:
Raw Material Control: Verification of incoming HA raw materials and other formulation components according to defined specifications.
Formulation Control: Controlled preparation of the HA gel to maintain composition and physical characteristics within established specifications.
Cross-Linking Control: Where a cross-linked HA formulation is used, the cross-linking process must be controlled to achieve the specified gel properties.
Homogenization: Controlled processing helps reduce variation within the finished gel and supports consistent filling performance.
Aseptic / Sterile Processing: Sterile production and packaging processes are critical for injectable products.
Filling Accuracy: Controlled filling equipment is used to maintain the specified syringe volume and reduce filling variation.
Finished Product Inspection: Finished products should be evaluated according to applicable specifications for appearance, packaging integrity, sterility, and other defined quality attributes.
OEM and Private Label Supply
Product Specification: HA concentration, gel formulation, syringe volume, needle configuration, and other product-specific parameters.
Packaging: Primary packaging, secondary carton, labeling language, artwork, and unit configuration.
Regulatory Documentation: Technical and quality documents required for the intended market and registration pathway.
Production Batch: Minimum Order Quantity (MOQ), production schedule, batch size, and repeat-order requirements.
Quality Consistency: The OEM specification should remain controlled across subsequent production batches.
FAQ
Q: What is a Hyaluronic Acid Depressed Scar Filler?
A: It is an injectable HA-based filler intended for selected depressed or atrophic scar applications, subject to the approved indication of the specific product model.
Q: What type of scars can HA filler be used for?
A: HA fillers may be considered for selected depressed or atrophic scars. Suitability depends on scar morphology, tissue condition, treatment area, product indication, and clinical assessment.
Q: Is the product suitable for all types of acne scars?
A: No. Depressed scar types differ in depth, structure, and tissue attachment. Product suitability should be determined by a qualified medical professional according to the specific indication and product labeling.
Q: What HA concentration is available?
A: HA concentration depends on the product model. The exact concentration should be confirmed from the technical specification before ordering.
Q: Is the filler cross-linked?
A: Cross-linking depends on the selected product formulation. The degree and method of cross-linking should be confirmed in the product technical documentation.
Q: What syringe sizes are available?
A: Syringe volume depends on the product model and OEM configuration. Standard and customized configurations can be discussed according to the intended market and application.
Q: Can the product be supplied under a private label?
A: OEM and private-label supply can be evaluated according to product specification, packaging requirements, MOQ, documentation, and target-market regulations.
Q: What documents are available for importers?
A: Documentation may include product specifications, quality certificates, sterility-related documents, labeling, IFU, and regulatory documents applicable to the destination market.
Q: Can the product be registered in target international markets?
A: Market access depends on the product classification, intended use, claims, and applicable regulatory pathway. The required documentation should be assessed for the specific destination market before registration.
Q: How should buyers compare different HA scar fillers?
A: Compare HA concentration, cross-linking profile, rheological properties, injection characteristics, syringe configuration, sterility, shelf life, regulatory documentation, manufacturing controls, and total procurement cost rather than price alone.
Hot Tags: hyaluronic acid depressed scar filler, China hyaluronic acid depressed scar filler manufacturers, suppliers, factory
